Given these findings, we next investigated whether liver cancer development and progression, which were greatly enhanced by p53 deficiency as all mutant mice developed tumors, might be accompanied and potentially aggravated by changes in iron metabolism. This evidence concerns the gene TP53 and liver cancer.